These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21943149)

  • 1. MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.
    Rota R; Ciarapica R; Giordano A; Miele L; Locatelli F
    Mol Cancer; 2011 Sep; 10():120. PubMed ID: 21943149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in skeletal muscle development and rhabdomyosarcoma (review).
    Ju H; Yang Y; Sheng A; Jiang X
    Mol Med Rep; 2015 Jun; 11(6):4019-24. PubMed ID: 25633282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated Myogenesis in Rhabdomyosarcoma.
    Yu PY; Guttridge DC
    Curr Top Dev Biol; 2018; 126():285-297. PubMed ID: 29305002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives.
    Romania P; Bertaina A; Bracaglia G; Locatelli F; Fruci D; Rota R
    Int J Mol Sci; 2012 Dec; 13(12):16554-79. PubMed ID: 23443118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis.
    Novák J; Vinklárek J; Bienertová-Vašků J; Slabý O
    Pediatr Blood Cancer; 2013 Nov; 60(11):1739-46. PubMed ID: 23813576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNAs as Players in Rhabdomyosarcoma Development.
    Gasparini P; Ferrari A; Casanova M; Limido F; Massimino M; Sozzi G; Fortunato O
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
    Zhang M; Zhu B; Davie J
    J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
    Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
    Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members.
    Megiorni F; Cialfi S; McDowell HP; Felsani A; Camero S; Guffanti A; Pizer B; Clerico A; De Grazia A; Pizzuti A; Moles A; Dominici C
    BMC Cancer; 2014 Nov; 14():880. PubMed ID: 25427715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
    Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
    J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation.
    Nicolai S; Pieraccioli M; Smirnov A; Pitolli C; Anemona L; Mauriello A; Candi E; Annicchiarico-Petruzzelli M; Shi Y; Wang Y; Melino G; Raschellà G
    Mol Oncol; 2020 Feb; 14(2):294-308. PubMed ID: 31782884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development.
    Cieśla M; Dulak J; Józkowicz A
    Int J Biochem Cell Biol; 2014 Aug; 53():482-92. PubMed ID: 24831881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
    Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
    Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
    Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
    Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells.
    Rao PK; Missiaglia E; Shields L; Hyde G; Yuan B; Shepherd CJ; Shipley J; Lodish HF
    FASEB J; 2010 Sep; 24(9):3427-37. PubMed ID: 20466878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.
    Marchesi I; Giordano A; Bagella L
    Cell Cycle; 2014; 13(4):516-27. PubMed ID: 24496329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.
    Wang H; Garzon R; Sun H; Ladner KJ; Singh R; Dahlman J; Cheng A; Hall BM; Qualman SJ; Chandler DS; Croce CM; Guttridge DC
    Cancer Cell; 2008 Nov; 14(5):369-81. PubMed ID: 18977326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in skeletal myogenesis.
    Ge Y; Chen J
    Cell Cycle; 2011 Feb; 10(3):441-8. PubMed ID: 21270519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.
    Taulli R; Bersani F; Foglizzo V; Linari A; Vigna E; Ladanyi M; Tuschl T; Ponzetto C
    J Clin Invest; 2009 Aug; 119(8):2366-78. PubMed ID: 19620785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
    Drummond CJ; Hanna JA; Garcia MR; Devine DJ; Heyrana AJ; Finkelstein D; Rehg JE; Hatley ME
    Cancer Cell; 2018 Jan; 33(1):108-124.e5. PubMed ID: 29316425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.